P

PerkinElmer

Analytical instruments and software for health

Validation Manager / Senior Manager

Full-TimeUpdated on 10/22/2026
$106k - $149.5k/yr
Senior, Expert
Bachelor's, Master's
Houston, TX, USA+6 moreMore locations: Los Angeles, CA, USA | Pasadena, CA, USA | South San Francisco, CA, USA | Portland, OR, USA | Boulder, CO, USA | San Diego, CA, USA
In PersonRequires domestic travel to client projects and travel as needed for business development and team initiatives.
Biology & BiotechRegulatory & Quality (Life Sciences)
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree and/or master's degree in Life Science, Engineering, or a related discipline, or equivalent experience in CQV engineering, cGMP facility start-up, project management, or comparable military experience.
  • Seven to thirteen years of advanced therapy, life science, pharmaceutical, or biotech experience.
  • At least four years of experience managing high-performing teams.
  • At least two years of business development, lead generation, or sales experience.
  • Willingness to travel as required for client project assignments and business development and team-member initiatives.
  • Experience operating as a trusted strategic advisor to organization decision-makers on short- and long-term organizational initiatives.
  • Experience translating client visions to set direction, frame projects, provide clarity to direct reports and clients, and deliver results.
  • Proven technical and managerial capabilities in developing solutions to engineering and business problems and managing deliverables and client expectations.
  • Applicants must be authorized to work in the United States on a full-time basis.
  • A valid driver's license is required.
Responsibilities
  • Develop and own the site strategy to position the firm as a leader in commissioning, qualification, and validation services.
  • Create a strategic roadmap to drive site growth and align with firm objectives.
  • Proactively identify client needs to foster site expansion.
  • Build and maintain relationships with key stakeholders, including client executives and decision-makers, to secure long-term partnerships.
  • Drive site-level business expansion and development, focusing on expanding services and opportunities.
  • Work with Project Leads to maintain dashboards and pursue expansion opportunities.
  • Own project extensions and proposal generation, and provide critical input into site requests for proposals.
  • Participate in industry events to build a local network and collaborate with the Market Director to expand client portfolios and secure high-value contracts.
  • Monitor and achieve operational key performance indicators and targets.
  • Analyze project performance metrics to ensure operational health and identify strategic opportunities for scaling.
  • Lead, oversee, and execute client project initiatives to identify new and additional services that benefit the client and organization.
  • Support, review, and analyze business development, project delivery, and team-member activities.
  • Support the development, implementation, and execution of strategic plans to meet business development and growth targets.
  • Collaborate across practice teams to develop solutions for joint business opportunities that meet business and client objectives.
  • Monitor and manage budgets and planning needs to meet project requirements.
  • Support maintenance of new and existing client accounts, focusing on project delivery and actively seeking account growth.
  • Work with clients' business and technical leaders to facilitate workflow development, project-scope development, risk assessment, issue resolution, work forecasting, and planning.
  • Provide direction and innovation in service and process improvement, cost reduction, and business-process optimization.
  • Remain current with biomanufacturing industry trends and implement strategies that leverage marketplace changes into business opportunities.
  • Represent Project Farma at ISPE and other networking events.
  • Oversee the career development and performance of the entire site team.
  • Coach, mentor, and develop team leads to prepare them for leadership roles.
  • Mentor, train, and coach team members in client engagement, relationship management, and leadership.
  • Develop and maintain succession plans for team or project leads.
  • Partner with Market Directors to share best practices across sites.
  • Lead a high-performing team, foster accountability, excellence, and collaboration, and set performance goals to enhance retention.
  • Manage teams at client sites to ensure consistency of technical services and compliance with client and Project Farma processes and standards.
  • Collaboratively identify and implement employee performance and development plans to meet individual development and organizational growth goals.
  • Direct and manage teams executing projects within practice areas, with overall responsibility for technical solutions, cost, quality, and client satisfaction.
  • Strategically assign team members to accounts and identify succession plans to maximize readiness of future leaders.
  • Lead initiatives and projects by ensuring team members understand team and individual goals and responsibilities, managing priorities, and ensuring timely, high-quality completion of work.
  • Provide technical direction, training, career development, and performance assessments as a subject matter expert to ensure high-quality delivery.
  • Identify professional development opportunities for team members.
  • Build and maintain high-performing teams to support successful account management and growth.
  • Identify talent needs and support recruitment and talent acquisition.
  • Drive resourcing decisions for the site and collaborate with Market Directors to ensure optimal staffing.
  • Consult with the Market Director to forecast future resource needs and maintain a forward-looking resource plan.
  • Manage resource utilization and team mix to ensure high-quality project delivery within budget.
  • Support project direction and strategy throughout the project delivery life cycle based on client vision and expected outcomes, without oversight.
  • Support resource planning and define project objectives and requirements needed to structure a project or activity.
  • Analyze project-management tools and trends, manage burn rates, identify the need for proposals, and communicate project performance; use earned-value analysis to support client success and maximize performance.
  • Drive efficiency through team-member utilization and support cross-account and cross-region allocations.
  • Oversee technical delivery for site or market projects to ensure high-quality outcomes.
  • Ensure appropriate staffing to meet project requirements and client expectations.
  • Serve as a technical subject matter expert to clients and as an escalation point for technical issues.
  • Ensure delivery of high-quality good manufacturing practice engineering services that meet client specifications and regulatory standards.
  • Own and delegate project execution to ensure timelines and budgets are met.
  • Continually develop technical aptitude in Project Farma's core life-science services.
  • As needed, assist with project controls and scheduling, including budget estimates, detailed project schedules and milestones, feasibility estimates, risks, forecasts and scenario analysis, and project cost reports and trend analysis.
  • Maintain 100% individual billability while ensuring the site or market team achieves forecast hours and targets.
  • Ensure team performance aligns with billable-hour operational goals.

About the company

PerkinElmer provides analytical instruments, software, and services for the life sciences, diagnostics, and environmental health markets. Customers use these tools to collect and analyze data through a combination of hardware, consumable supplies, and software licensing. Unlike many competitors, the company integrates a global service network with a focus on sustainability by designing products that reduce waste and energy consumption. Its goal is to improve human and environmental health by helping laboratories and industrial companies achieve more efficient and accurate scientific results.

Company Size

5,001-10,000

Company Stage

Acquired

Total Funding

$2.5B

Headquarters

Shelton, Connecticut

Founded

1937

Get referred to PerkinElmer

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • SimoTech closed September 3, 2026, expanding PerkinElmer's pharma automation and GMP IT services.
  • Covalent collaboration, July 7, 2026, opens semiconductor, electronics, and battery failure-analysis demand.
  • eXXpedition and Avio 3000 strengthen PerkinElmer's sustainability and environmental-monitoring positioning in 2026.

What critics are saying

  • Shelton manufacturing closes April 1, 2026, eliminating 68 jobs and local production capacity.
  • Private-equity ownership under New Mountain Capital pressures margins, integration, and employee retention through 2026.
  • Diagnostics and instrumentation rivals like Thermo Fisher and Agilent can outspend PerkinElmer on R&D and distribution.

What makes PerkinElmer unique

  • PerkinElmer spans instruments, services, and GMP digital manufacturing through SimoTech, 2026-09-03.
  • Its ICP-MS/MS and LC-MS/MS stack serves semiconductors, batteries, and pharma, 2026-07-07.
  • Avio 3000 and LactoScope 500 target lower-cost, lower-maintenance workflow ownership, 2026-05-29.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Contract Pharma
Sep 3rd, 2026
PerkinElmer completes SimoTech acquisition.

PerkinElmer completes SimoTech acquisition. Deal expands PerkinElmer's automation, GMP IT and digital manufacturing capabilities for life sciences customers. September 3, 2026 Associate Editor, Contract Pharma PerkinElmer has completed its acquisition of SimoTech, adding end-to-end GMP automation and digital manufacturing capabilities to its life sciences services platform. The transaction follows PerkinElmer's August agreement to acquire the company and deepens its support for biopharmaceutical customers seeking to accelerate development and manufacturing of life-saving treatments. Founded in 2011 and headquartered in Cork, Ireland, SimoTech is a manufacturing automation and technology services provider in the biopharmaceutical market, supporting half of the world's top 20 pharmaceutical and biotechnology companies. It works with life sciences organizations to develop, implement and manage automation and digital manufacturing solutions that accelerate project execution, improve operational performance, increase manufacturing flexibility and maintain regulatory compliance. For PerkinElmer, the acquisition broadens its life sciences offering by combining SimoTech's automation and GMP IT expertise with OneSource integrated laboratory and digital solutions and Project Farma's manufacturing and engineering services platform. "By combining SimoTech's expertise in manufacturing automation and digital systems with the capabilities of OneSource and Project Farma, this acquisition creates a significant opportunity to build a differentiated, scaled platform for pharmaceutical services," said Michael Stubblefield, CEO, PerkinElmer. "We are excited to welcome SimoTech's exceptional team to the PerkinElmer family." "The combination of OneSource, Project Farma and SimoTech creates a unique opportunity to strengthen our partnerships with leading innovators and reduce the time to market for life-changing therapies. SimoTech's expertise in automation and IT systems is a natural complement to our capabilities, enabling us to support customers across the full drug development and manufacturing lifecycle. Together, we bring highly complementary capabilities that position us to deliver greater value to our customers, unlock new opportunities for growth, and realize the full potential of a differentiated, scaled pharmaceutical services platform," said Anshul Mangal, President of PerkinElmer's Pharma Specialty Services business. Other Pharma industry acquisitions.

PR Newswire
Jul 7th, 2026
PerkinElmer and Covalent announce strategic collaboration to advance failure analysis and materials characterization for semiconductor, electronics, and battery industries.

PerkinElmer and Covalent announce strategic collaboration to advance failure analysis and materials characterization for semiconductor, electronics, and battery industries. Jul 07, 2026, 14:28 ET Collaboration pairs PerkinElmer's ICP-MS/MS and LC-MS/MS technologies with Covalent's failure analysis expertise to help manufacturers pinpoint the root causes of material failure and performance degradation. SHELTON, Conn. and SUNNYVALE, Calif., July 7, 2026 /PRNewswire/ - PerkinElmer and Covalent today announced a strategic collaboration to provide advanced analytical instrumentation and analysis services that address the growing complexity of failure analysis and materials characterization. In the high-stakes fields of advanced electronics, semiconductor manufacturing, energy storage, and other precision-materials industries, identifying the root causes of material failures and performance drops is essential. Component degradation, trace chemical contamination, and structural breakdowns require highly sensitive analytical tools capable of detecting the smallest indicators of a larger problem. Utilizing Inductively Coupled Plasma Mass Spectrometry (ICP-MS/MS) and Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS), researchers and manufacturers can track down ultra-trace elemental impurities and organic degradation mechanisms. These techniques optimize manufacturing quality control and accelerate root-cause failure analysis. "This is an important partnership to help us better understand the analysis challenges facing the semiconductor, electronics, and battery industries," said Paul Davies, Vice President, North America, PerkinElmer. "Covalent is a well-respected subject matter expert in this space and will be an invaluable voice of the customer, helping us push the boundaries of what ICP-MS/MS, LC-MS/MS, and other technologies in our portfolio are capable of in failure analysis, raw material characterization, and battery lifetime diagnostics." "PerkinElmer has been a trusted leader in analytical science for decades, and we are honored that they chose to partner with us for these critical applications," said Craig Hunter, CEO of Covalent. "As materials systems and product designs become more complex, the ability to combine cutting-edge instrumentation with expert application knowledge is more important than ever. Our partnership with PerkinElmer will help customers gain deeper insight into the mechanisms that drive performance and reliability." PerkinElmer's ICP-MS/MS delivers unmatched sensitivity for ultra-trace chemical analysis of metallic impurities before they deposit on silicon or compound-silicon wafers. The technique can also characterize the corrosion, solder joint deterioration, and migratory short-circuiting that cause modern printed circuit boards and electronic packages to fail. PerkinElmer's LC-MS/MS technology provides electrolyte degradation profiling for battery performance analysis and helps characterize the chemical degradation of coatings and epoxy mold compounds in electronic components. These same capabilities extend to impurity profiling, medical device characterization, and broader precision-materials work where chemical sensitivity is the binding constraint. About PerkinElmer PerkinElmer is a global leader in analytical and testing solutions, pharma specialty services, and omics solutions, serving customers across the life sciences, applied & industrial, and food. Drawing on nearly 90 years of pioneering innovation and engineering expertise, we support the science of our customers with insights of the highest standards of safety, quality and compliance for vital therapeutics, the integrity of the global food chain, the performance and sustainability of critical materials, and the sustainability of our environment. Together with scientists, laboratory and quality leaders, and manufacturing operators worldwide, our 5,500 colleagues in 35 countries empower progress by providing trusted insights and services for a healthier, safer, and more sustainable world. Media Contact Markus Leutert VP, Corporate Communications & Sustainability About Covalent Covalent is a leading materials characterization and failure analysis laboratory that helps companies solve complex engineering and manufacturing challenges. With expertise spanning semiconductor, electronics, battery, aerospace, medical device, and advanced materials industries, Covalent combines world-class scientific expertise with more than 100 analytical techniques to deliver actionable insights that improve product performance, reliability, and manufacturing quality. Learn more at www.covalent.com. Media Contact Sophia Attaf Director of Marketing SOURCE Covalent

Envirotech Online
May 29th, 2026
A new benchmark for high throughput cost efficient ICP OES.

A new benchmark for high throughput cost efficient ICP OES. 29 May, 2026 PerkinElmer AES (UK) Limited Building on decades of ICP-OES innovation and market leadership, the Avio(R) 3000 expands PerkinElmer's portfolio, enabling high-speed analysis with outstanding stability and detection limits, low operating costs, and simplified workflows that deliver accurate, defensible data. PerkinElmer recently announced the launch of the Avio(R) 3000 inductively coupled plasma optical emission spectrometer, their top-tier true simultaneous ICP-OES. Engineered to support laboratories operating under constant throughput and cost pressures, the Avio 3000 delivers rapid ICP-OES analysis alongside data consistency required for regulatory-driven environments. Optimised for efficiency and reliability, the system reduces consumables, energy use, and operational complexity to deliver measurable cost savings. The combination of high performance and low operating costs in the Avio 3000 ICP-OES is made possible by the seamless integration of third-generation proprietary technologies with field-proven ones, allowing laboratories to achieve high analytical performance while maintaining efficient, cost-effective operation. Third-generation proprietary technologies include: a patented detector designed exclusively for ICP-OES, delivering improved signal-to-background ratio, precision, and speed; a cutting-edge optical system that enhances data quality while simplifying operation; patented HeliPlate(TM) plasma technology that consumes up to 50% less argon than traditional helical coil systems while improving plasma robustness; chiller-free operation further contributes to savings in electricity, heat, noise, and maintenance, reduces the carbon footprint, and occupies less laboratory space. The Avio 3000 builds on a strong tradition of reliable, low-maintenance instrumentation, providing a high-performance true simultaneous ICP-OES system with reduced on-going operating costs.

Chemicals Press Releases
May 25th, 2026
PerkinElmer partners with eXXpedition to advance ocean science and a more sustainable future.

PerkinElmer partners with eXXpedition to advance ocean science and a more sustainable future. SHELTON, CT, UNITED STATES, May 25, 2026 / EINPresswire.com / - PerkinElmer, a global leader in analytical solutions that support human and environmental health, today announced a partnership with eXXpedition, the all-women global sailing research organization dedicated to investigating the causes and impacts of plastic pollution in the marine environment. The partnership reflects a shared commitment to advancing ocean science and accelerating progress toward a more sustainable future. eXXpedition's latest mission will deliver the first global study mapping ocean plastic pollution back to its sources on land. With the second leg of the voyage underway, PerkinElmer is supporting the mission by equipping eXXpedition with advanced FTIR spectroscopy technology, polymer spectral libraries, and sampling accessories to analyze microplastics collected at sea and on land. FTIR technology enables scientists to quickly and accurately identify different types of plastic in ocean samples, helping generate reliable data that deepens understanding of plastic and microplastic pollution and informs solutions to protect ocean and human health. The collaboration reinforces PerkinElmer's commitment to advancing a more sustainable future through science, innovation, and meaningful partnerships. Founded by ocean advocate and skipper Emily Penn, eXXpedition combines offshore sailing expeditions with rigorous scientific sampling, policy engagement, and public education. Crew members collect water samples across some of the world's most remote ocean regions to study microplastics, persistent organic pollutants, and the chemical signatures associated with plastic waste. On land, the team completes the picture by conducting investigations into litter, consumer goods packaging, and waste management infrastructure. "Plastic pollution is a global challenge that crosses borders and ecosystems, with consequences for ocean health, food systems, and human well-being," said Michael Stubblefield, CEO of PerkinElmer. "On World Environment Day, this partnership highlights the importance of credible science and cross-sector collaboration to better understand how plastics move through the environment and to help protect both the planet and human health." Science at the Heart of Sustainability PerkinElmer contributes to sustainability through a broad portfolio of products and services that support environmental monitoring, materials characterization, and clean-energy research. These technologies play a critical role in helping scientists, regulators, and industry better understand environmental risks and accelerate the transition to more sustainable systems. As part of this partnership, PerkinElmer contributes its state-of-the-art Fourier Transform Infrared (FTIR) spectroscopy, a powerful analytical technique widely used to identify and characterize plastics and polymers. FTIR enables researchers to: - Identify the chemical composition of microplastics collected from seawater - Distinguish between polymer types and potential sources of pollution - Support robust, comparable datasets that can inform environmental policy and innovation FTIR analysis is a cornerstone of many microplastics research workflows, helping transform ocean samples into data that can drive meaningful action. ABOUT PERKINELMER PerkinElmer is a global leader in analytical, measurement, testing, and bespoke life sciences services, serving customers across the life sciences, applied & industrial, and food markets. Drawing on nearly 90 years of pioneering innovation and engineering expertise, Chemicalspressreleases support the science of its customers with insights of the highest standards of safety, quality and compliance for vital therapeutics, the integrity of the global food chain, the performance and sustainability of critical materials, and the sustainability of its environment. Together with scientists, laboratory and quality leaders, and manufacturing operators worldwide, its 5,000 colleagues in 35 countries empower progress by providing trusted insights and services for a healthier, safer, and more sustainable world. For more information, visit: www.perkinelmer.com ABOUT EXXPEDITION At eXXpedition Chemicalspressreleases lead ocean research missions to help people truly connect with the plastic crisis and discover their unique role in tackling it. Founded by ocean advocate Emily Penn, Chemicalspressreleases take people to sea to witness the plastic problem first-hand, contribute to groundbreaking scientific research and bring back stories that inspire change. On board, its multinational, multidisciplinary all-women crews connect with the ocean and with each other in ways that change them forever. Back on land, they carry the experience into their work and communities, creating a ripple effect of change in how the world tackles plastic pollution. Since setting sail 12 years ago, eXXpedition has run 29 missions with 274 participants from 41 nations around the world. Chemicalspressreleases has partnered with hundreds of organisations, contributed data to 35 scientific studies, and seen its alumni drive change through policy, product design, film-making, and almost 2,000 media interviews. You can find out more about eXXpedition's approach and impact here: eXXpedition.com Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. Chemicalspressreleases do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Associated Press
May 13th, 2026
PerkinElmer launches LactoScope 500 dairy analyser for improved accuracy and efficiency

Perten, a PerkinElmer company, has launched the LactoScope 500, a Fourier Transform Infrared Spectroscopy dairy analyser designed for medium and large processors. The system addresses measurement instability challenges in traditional FT-IR systems, particularly for high-fat or viscous products. The LactoScope 500 features a fully integrated dual-stage high-pressure homogeniser that standardises samples within the instrument, reducing variability and improving accuracy for products like cream, yogurt and ice cream mixes. It provides rapid analysis of fat, lactose, protein and total solids, enabling processors to operate with tighter specifications and reduce product giveaway. The system combines mid-infrared optics, stable calibration models and integrated remote diagnostics for consistent long-term performance. Its compact design includes an intuitive touchscreen and lower consumables usage to support sustainability initiatives.